OTC · Biotechnology

HAVN Life Sciences Inc. (HAVLF) Stock

$0.00 OTC: HAVLF Healthcare

HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms.

Valuation

MetricValue
Price$0.00
Market Cap$2565
P/E Ratio-0.01
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.44
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-234.52%
ROA-30.27%
ROCE-284.27%
Gross Margin35.54%
Operating Margin5362.73%
Net Margin0.00%
Debt/Equity0.03
Current Ratio2.68

Annual Financials (USD)

Metric202020212022
Revenue$0$0$0
Operating Profit$0$-30.0M$-10.0M
Net Profit$0$-30.0M$-22.0M
EPS$-0.02$-8.47$-5.25
Op Margin——-3548.4%

Balance Sheet (USD)

Metric202020212022
Total Assets$2.0M$14.0M$4.0M
Total Liabilities$0$1.0M$1.0M
Cash$2.0M$9.0M$1.0M
Borrowings$0$0$0

Cash Flow (USD)

Metric202020212022
Operating Cash Flow$0$-10.0M$-8.0M
Investing Cash Flow$0$0$-2.0M
Financing Cash Flow$0$5.0M$0
Net Cash Flow$2.0M$8.0M$-8.0M
Free Cash Flow$0$-10.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.02
FCF Yield-691.30%
Quick Ratio2.62
Interest Coverage-152.94
Return 1Y-95.00%
Return 3Y-99.30%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADXSAyala Pharmaceuticals, Inc. $0.60 +0.00% -0.08 $25.71M 0.00%
ARUXFAcrux Limited $0.02 +0.00% -1.90 $6.78M 0.00%
AXIMAXIM Biotechnologies, Inc. $0.00 — -2.00 $1.02M 0.00%
NRPRResilient Healthcare Corp $0.02 +0.00% — $2.11M 0.00%
PKTXProtoKinetix, Incorporated $0.00 — -1.00 $156632 0.00%

About HAVN Life Sciences Inc.

HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients. Founded in 2020, HAVN Life Sciences' operations are headquartered in Richmond, Canada.

HAVN Life Sciences Inc. (HAVLF) stock trades at $0.00 with a market capitalization of $2565. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, HAVN Life Sciences Inc. generates a return on equity (ROE) of -234.52%, return on capital employed of -284.27%, an operating margin of 5362.73%, a net profit margin of 0.00%.

Official website: www.havnlife.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides